PDB Short entry for 1F42 HEADER CYTOKINE 07-JUN-00 1F42 TITLE THE P40 DOMAIN OF HUMAN INTERLEUKIN-12 CAVEAT 1F42 MAN B 3 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-12 BETA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 23-328; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PEMC KEYWDS CYTOKINE EXPDTA X-RAY DIFFRACTION AUTHOR C.YOON,S.C.JOHNSTON,J.TANG,J.F.TOBIN,W.S.SOMERS REVDAT 5 29-JUL-20 1F42 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1F42 1 VERSN REVDAT 3 24-FEB-09 1F42 1 VERSN REVDAT 2 07-JAN-03 1F42 1 REMARK REVDAT 1 13-JUN-01 1F42 0 JRNL AUTH C.YOON,S.C.JOHNSTON,J.TANG,M.STAHL,J.F.TOBIN,W.S.SOMERS JRNL TITL CHARGED RESIDUES DOMINATE A UNIQUE INTERLOCKING TOPOGRAPHY JRNL TITL 2 IN THE HETERODIMERIC CYTOKINE INTERLEUKIN-12. JRNL REF EMBO J. V. 19 3530 2000 JRNL REFN ISSN 0261-4189 JRNL PMID 10899108 JRNL DOI 10.1093/EMBOJ/19.14.3530 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 12304 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 615 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2336 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 55 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 BOND ANGLES (DEGREES) : 1.880 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1F42 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-JUN-00. REMARK 100 THE DEPOSITION ID IS D_1000011216. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.542 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 90266 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 35.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.16000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MLPHARE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG8000, 0.2M CALCIUM ACETATE, REMARK 280 0.1M NA CACODYLATE, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 94.60000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 94.60000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 140 REMARK 465 SER A 141 REMARK 465 ASP A 142 REMARK 465 PRO A 143 REMARK 465 GLN A 144 REMARK 465 GLU A 262 REMARK 465 LYS A 263 REMARK 465 LYS A 264 REMARK 465 ASP A 265 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 99 CG CD CE NZ REMARK 470 GLU A 100 CG CD OE1 OE2 REMARK 470 LYS A 102 CG CD CE NZ REMARK 470 ASN A 103 CG OD1 ND2 REMARK 470 LYS A 104 CG CD CE NZ REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 LYS A 225 CG CD CE NZ REMARK 470 ARG A 279 CG CD NE CZ NH1 NH2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 6 CD CE NZ REMARK 480 LYS A 96 CD CE NZ REMARK 480 LYS A 280 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 252 CA CYS A 252 CB 0.135 REMARK 500 VAL A 253 N VAL A 253 CA 0.222 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 252 CB - CA - C ANGL. DEV. = 11.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 41 -118.47 47.49 REMARK 500 THR A 92 48.52 -140.68 REMARK 500 LYS A 99 -0.08 52.33 REMARK 500 LYS A 102 68.94 -163.47 REMARK 500 ASN A 103 150.13 52.17 REMARK 500 ASN A 113 -168.93 -162.04 REMARK 500 LYS A 195 -95.31 58.15 REMARK 500 SER A 295 -158.03 -91.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 114 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1F45 RELATED DB: PDB REMARK 900 1F45 CONTAINS INTERLEUKIN-12 BETA CHAIN AND INTERLEUKIN-12 ALPHA REMARK 900 CHAIN DBREF 1F42 A 1 306 UNP P29460 I12B_HUMAN 23 328 SEQRES 1 A 306 ILE TRP GLU LEU LYS LYS ASP VAL TYR VAL VAL GLU LEU SEQRES 2 A 306 ASP TRP TYR PRO ASP ALA PRO GLY GLU MET VAL VAL LEU SEQRES 3 A 306 THR CYS ASP THR PRO GLU GLU ASP GLY ILE THR TRP THR SEQRES 4 A 306 LEU ASP GLN SER SER GLU VAL LEU GLY SER GLY LYS THR SEQRES 5 A 306 LEU THR ILE GLN VAL LYS GLU PHE GLY ASP ALA GLY GLN SEQRES 6 A 306 TYR THR CYS HIS LYS GLY GLY GLU VAL LEU SER HIS SER SEQRES 7 A 306 LEU LEU LEU LEU HIS LYS LYS GLU ASP GLY ILE TRP SER SEQRES 8 A 306 THR ASP ILE LEU LYS ASP GLN LYS GLU PRO LYS ASN LYS SEQRES 9 A 306 THR PHE LEU ARG CYS GLU ALA LYS ASN TYR SER GLY ARG SEQRES 10 A 306 PHE THR CYS TRP TRP LEU THR THR ILE SER THR ASP LEU SEQRES 11 A 306 THR PHE SER VAL LYS SER SER ARG GLY SER SER ASP PRO SEQRES 12 A 306 GLN GLY VAL THR CYS GLY ALA ALA THR LEU SER ALA GLU SEQRES 13 A 306 ARG VAL ARG GLY ASP ASN LYS GLU TYR GLU TYR SER VAL SEQRES 14 A 306 GLU CYS GLN GLU ASP SER ALA CYS PRO ALA ALA GLU GLU SEQRES 15 A 306 SER LEU PRO ILE GLU VAL MET VAL ASP ALA VAL HIS LYS SEQRES 16 A 306 LEU LYS TYR GLU ASN TYR THR SER SER PHE PHE ILE ARG SEQRES 17 A 306 ASP ILE ILE LYS PRO ASP PRO PRO LYS ASN LEU GLN LEU SEQRES 18 A 306 LYS PRO LEU LYS ASN SER ARG GLN VAL GLU VAL SER TRP SEQRES 19 A 306 GLU TYR PRO ASP THR TRP SER THR PRO HIS SER TYR PHE SEQRES 20 A 306 SER LEU THR PHE CYS VAL GLN VAL GLN GLY LYS SER LYS SEQRES 21 A 306 ARG GLU LYS LYS ASP ARG VAL PHE THR ASP LYS THR SER SEQRES 22 A 306 ALA THR VAL ILE CYS ARG LYS ASN ALA SER ILE SER VAL SEQRES 23 A 306 ARG ALA GLN ASP ARG TYR TYR SER SER SER TRP SER GLU SEQRES 24 A 306 TRP ALA SER VAL PRO CYS SER MODRES 1F42 ASN A 200 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET MAN B 3 11 HET MNB A 504 13 HET MNB A 505 13 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM MNB 5-MERCAPTO-2-NITRO-BENZOIC ACID FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 2 MAN C6 H12 O6 FORMUL 3 MNB 2(C7 H5 N O4 S) FORMUL 5 HOH *55(H2 O) HELIX 1 1 GLU A 59 ALA A 63 5 5 HELIX 2 2 PHE A 206 ILE A 211 1 6 SHEET 1 A 6 GLY A 48 SER A 49 0 SHEET 2 A 6 THR A 37 LEU A 40 -1 N TRP A 38 O GLY A 48 SHEET 3 A 6 GLY A 64 LYS A 70 -1 N THR A 67 O THR A 39 SHEET 4 A 6 GLU A 73 GLU A 86 -1 N GLU A 73 O LYS A 70 SHEET 5 A 6 VAL A 8 ASP A 14 1 N TYR A 9 O LEU A 79 SHEET 6 A 6 TRP A 2 LYS A 5 -1 O TRP A 2 N VAL A 10 SHEET 1 B 5 GLY A 48 SER A 49 0 SHEET 2 B 5 THR A 37 LEU A 40 -1 N TRP A 38 O GLY A 48 SHEET 3 B 5 GLY A 64 LYS A 70 -1 N THR A 67 O THR A 39 SHEET 4 B 5 GLU A 73 GLU A 86 -1 N GLU A 73 O LYS A 70 SHEET 5 B 5 ILE A 89 TRP A 90 -1 N ILE A 89 O GLU A 86 SHEET 1 C 2 GLU A 22 THR A 27 0 SHEET 2 C 2 THR A 52 VAL A 57 -1 O LEU A 53 N LEU A 26 SHEET 1 D 4 THR A 152 ARG A 159 0 SHEET 2 D 4 ASN A 162 GLU A 173 -1 O ASN A 162 N ARG A 159 SHEET 3 D 4 ARG A 117 THR A 124 -1 N PHE A 118 O CYS A 171 SHEET 4 D 4 ARG A 108 GLU A 110 -1 O ARG A 108 N TRP A 121 SHEET 1 E 3 THR A 152 ARG A 159 0 SHEET 2 E 3 ASN A 162 GLU A 173 -1 O ASN A 162 N ARG A 159 SHEET 3 E 3 VAL A 146 CYS A 148 -1 N THR A 147 O GLN A 172 SHEET 1 F 3 LEU A 130 ARG A 138 0 SHEET 2 F 3 ILE A 186 HIS A 194 -1 N GLU A 187 O SER A 137 SHEET 3 F 3 LYS A 197 PHE A 205 -1 N LYS A 197 O HIS A 194 SHEET 1 G 3 LYS A 217 PRO A 223 0 SHEET 2 G 3 GLN A 229 GLU A 235 -1 O GLU A 231 N LYS A 222 SHEET 3 G 3 SER A 273 ILE A 277 -1 O ALA A 274 N VAL A 232 SHEET 1 H 4 VAL A 267 THR A 269 0 SHEET 2 H 4 LEU A 249 GLN A 256 -1 N PHE A 251 O THR A 269 SHEET 3 H 4 SER A 283 ASP A 290 -1 O SER A 283 N GLN A 256 SHEET 4 H 4 ALA A 301 PRO A 304 -1 O ALA A 301 N VAL A 286 SSBOND 1 CYS A 28 CYS A 68 1555 1555 2.03 SSBOND 2 CYS A 109 CYS A 120 1555 1555 2.04 SSBOND 3 CYS A 148 CYS A 171 1555 1555 2.04 SSBOND 4 CYS A 278 CYS A 305 1555 1555 2.03 LINK SG CYS A 177 S5 MNB A 504 1555 1555 2.03 LINK ND2 ASN A 200 C1 NAG B 1 1555 1555 1.44 LINK SG CYS A 252 S5 MNB A 505 1555 1555 2.03 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.38 LINK O4 NAG B 2 C1 MAN B 3 1555 1555 1.39 CISPEP 1 THR A 242 PRO A 243 0 -0.46 CRYST1 34.000 55.000 189.200 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029412 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018182 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005285 0.00000